← Eichor
Condition: Alcohol Liver Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Alcohol Liver Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Li
Phase N/A · 2 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07652892Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
NA · 11 location(s) · Pharmicell Co., Ltd. · NCT05093881Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05361603Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
NA · 1 location(s) · Phenomen Pharma · NCT07068191LGG Supplementation in Patients With AUD and ALD
Phase 2 · 1 location(s) · University of Louisville · NCT05178069French National MICMAF Cohort
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05895890Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05623150A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Phase 1 · 3 location(s) · GlaxoSmithKline · NCT07358546Evaluating Alcohol Use in Alcoholic Liver Disease
Phase N/A · 1 location(s) · Nicole T Shen · NCT03267069Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis
Phase 3 · 11 location(s) · Pharmicell Co., Ltd. · NCT04689152ADDICTOlogical Intervention in LIVEr Transplantation Recipients
NA · 16 location(s) · University Hospital, Montpellier · NCT06472973Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial
Phase 2 · 6 location(s) · Samer Gawrieh · NCT07060638SAMe Trial for Patients With Alcoholic Cirrhosis
Phase 2 · 2 location(s) · Indiana University · NCT04250259In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Pl
Phase 3 · 1 location(s) · Green Cross Wellbeing · NCT06493799ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
NA · 32 location(s) · Kirby Institute · NCT03685045Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis
Phase N/A · 1 location(s) · Hannover Medical School · NCT07169526Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06544863Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease
NA · 1 location(s) · Pusan National University Yangsan Hospital · NCT04320199Integrated Diagnostics for Early Diagnosis of Liver Disease
Phase N/A · 1 location(s) · Manchester University NHS Foundation Trust · NCT04666402Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality
NA · 1 location(s) · Clinica Universidad de Navarra, Universidad de Navarra · NCT06338215Risk and Protective Factors for Relapse to Alcohol Use in Patients With Liver Disease Undergoing Liver Transplantation
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06749990Study of Alcohol-related Liver Disease in Europe
Phase N/A · 1 location(s) · University Hospital, Lille · NCT04400604Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
NA · 3 location(s) · University of Wisconsin, Madison · NCT06305624Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial
NA · 1 location(s) · Zealand University Hospital · NCT06493773Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients
NA · 13 location(s) · University Hospital, Angers · NCT05699018Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH
NA · 1 location(s) · Johns Hopkins University · NCT03845205Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
NA · 1 location(s) · Maja Thiele · NCT03308916Efficacy of Simvastatin in Alcoholic Liver Fibrosis
Phase 2/Phase 3 · 1 location(s) · Anna Cruceta · NCT04971577Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients W
Phase N/A · 9 location(s) · University Hospital, Lille · NCT04106518
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.